16. Baka E, Comer JEA, Takacs-Novak K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal 2008; 46:335–41.
https://doi.org/10.1016/j.jpba.2007.10.030
17. Zhou L, Yang L, Tilton S, Wang J. Development of a high throughput equilibrium solubility assay using miniaturized shake-flask method in early drug discovery. J Pharm Sci 2007; 96:3052–71.
https://doi.org/10.1002/jps.20913
19. Obach RS. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of
in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 1999; 27:1350–9.
21. van de Waterbeemd H, Testa B. Drug bioavailability: estimation of solubility, permeability, absorption and bioavailability. Weinheim, Germany: Wiley-VCH; 2009.
25. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (
CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004; 14:1–18.
26. Azarara M, Afrasibirad A, Farzamikia N, Alijani A, Sakhinia E. The effect of GGCX and CYP4F2 gene polymorphisms in genotype-guided dosing of warfarin in patients with a history of cardiac surgery. J Pharm Invest 2017; 47:349–355.
https://doi.org/10.1007/s40005-016-0295-3
28. Zahner D, Alber J, Petzinger E. Cloning and heterologous expression of the ovine (
Ovis aries) P-glycoprotein (Mdr1) in Madin-Darby canine kidney (MDCK) cells. J Vet Pharmacol Ther 2010; 33:304–11.
https://doi.org/10.1111/j.1365-2885.2009.01141.x